Agent Capital is a health care venture capital firm focused on investing in novel therapeutics and innovative technology platforms that address unmet patient need.
Phone: 844-691-6233
204 Drakes Drum Drive
Bryn Mawr, 19010
Pennsylvania, United States
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2018-08-13 | Orchard Therapeutics | Series C | $150M | ArrowMark Partners, Baillie Gifford & Co., Cormorant Asset Management, Cowen Group, Deerfield Management, Driehaus Capital Management, Foresite Capital, Ghost Tree Capital Group, Medison Ventures, Perceptive Advisors, RA Capital Management, RTW Investments, Sphera Global Healthcare, Temasek Holdings, and Venrock |
| 2018-07-16 | Pliant Therapeutics | Series B | $62.15M | Bessemer Trust, Cowen Group, Eventide Asset Management, Menlo Ventures, S-Cubed Capital, and Schroder Adveq |
| 2018-07-16 | Verge Genomics | Series A | $32M | ALS Investment Fund, DFJ, OS Fund, and WuXi Healthcare Ventures |
| 2018-06-27 | Carisma Therapeutics | Series A | $53M | AbbVie Biotech Ventures, Grazia Equity, HealthCap Venture Capital, IP Group, MRL Ventures, Penn Medicine, TPG Biotech, and Wellington Partners |
| 2018-06-26 | Skyhawk Therapeutics | Series A | $40M | Alexandria Venture Investments, Duke of Bedford, GreatPoint Ventures, Reilly Family Office, ShangPharma, and Tim Disney |
